Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1Jingnan Zhang, Lili Ji, Xiyu Mei et al.|Acta Pharmaceutica Sinica B|2023Cited by 33